Pmhnp study set for ancc Study guides, Class notes & Summaries

NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022 100% solved -Graded A+   NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022 100% solved -Graded A+ 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply Age Rapid dose escalation Parental route of administration Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of the following effects? Reduces negative symptoms Increases e...

NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022 100% solved -Graded A+   NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022 100% solved -Graded A+ 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply Age Rapid dose escalation Parental route of administration Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of the following effects? Reduces negative symptoms Increases e...

ANCC PMHNP Study Set (Latest ) Actual Questions and Answers 100% Correct 1. 1. Review the MOA/DOSAGE for pharmacological therapy for a patient on a stimulant medication(s) for ADHD. (p. 747) Answer: **Note: medication therapy not first line **Beware of stimulant use for children with tics **Rx'ing stimulants: ALWAYS assess cardiac risk because can lead to sudden cardiac death a. MOA: inhibit reuptake of dopamine and norepinephrine, thereby increasing concentrations in the presynapti...

1. Review the MOA/DOSAGE for pharmacological therapy for a patient on a stimulant medication(s) for ADHD. (p. 747) **Note: medication therapy not first line **Beware of stimulant use for children with tics **Rx'ing stimulants: ALWAYS assess cardiac risk because can lead to sudden cardiac death a. MOA: inhibit reuptake of dopamine and norepinephrine, thereby increasing concentrations in the presynaptic cleft. Amphetamines directly stimulate the release of dopamine and norepinephrine. b. D...

1. Review the MOA/DOSAGE for pharmacological therapy for a patient on a stimulant medication(s) for ADHD. (p. 747) **Note: medication therapy not first line **Beware of stimulant use for children with tics **Rx'ing stimulants: ALWAYS assess cardiac risk because can lead to sudden cardiac death a. MOA: inhibit reuptake of dopamine and norepinephrine, thereby increasing concentrations in the presynaptic cleft. Amphetamines directly stimulate the release of dopamine and norepinephrine. b. D...

1. Review the MOA/DOSAGE for pharmacological therapy for a patient on a stimulant medication(s) for ADHD. (p. 747) **Note: medication therapy not first line **Beware of stimulant use for children with tics **Rx'ing stimulants: ALWAYS assess cardiac risk because can lead to sudden cardiac death a. MOA: inhibit reuptake of dopamine and norepinephrine, thereby increasing concentrations in the presynaptic cleft. Amphetamines directly stimulate the release of dopamine and norepinephrine. b. D...

1. Review the MOA/DOSAGE for pharmacological therapy for a patient on a stimulant medication(s) for ADHD. (p. 747) **Note: medication therapy not first line **Beware of stimulant use for children with tics **Rx'ing stimulants: ALWAYS assess cardiac risk because can lead to sudden cardiac death a. MOA: inhibit reuptake of dopamine and norepinephrine, thereby increasing concentrations in the presynaptic cleft. Amphetamines directly stimulate the release of dopamine and norepinephrine. b. D...

NRNP 6675 Week 11 Final Exam Questions and Answers   NRNP 6675 Week 11 Final Exam Question: 1 Concerns when treating geriatric patients with psychotherapeutic drugs include all of the following EXCEPT: A. Elderly persons may be more susceptible to adverse effects of psychotherapeutic drugs. B. Elderly persons may metabolize psychotherapeutic drugs more slowly. C. Elderly persons may metabolize psychotherapeutic drugs more rapidly. D. Elderly persons may excrete...

1. Review the MOA/DOSAGE for pharmacological therapy for a patient on a stimulant medication(s) for ADHD. (p. 747) **Note: medication therapy not first line **Beware of stimulant use for children with tics **Rx'ing stimulants: ALWAYS assess cardiac risk because can lead to sudden cardiac death a. MOA: inhibit reuptake of dopamine and norepinephrine, thereby increasing concentrations in the presynaptic cleft. Amphetamines directly stimulate the release of dopamine and norepinephrine. b. D...

NRNP 6675 Week 11 Final Exam Questions and Answers   NRNP 6675 Week 11 Final Exam Question: 1 Concerns when treating geriatric patients with psychotherapeutic drugs include all of the following EXCEPT: A. Elderly persons may be more susceptible to adverse effects of psychotherapeutic drugs. B. Elderly persons may metabolize psychotherapeutic drugs more slowly. C. Elderly persons may metabolize psychotherapeutic drugs more rapidly. D. Elderly persons may excrete...